By the same authors

From the same journal

Long term health care use and costs in patients with stable coronary artery disease: a population based cohort using linked electronic health records (CALIBER)

Research output: Contribution to journalArticle

Full text download(s)

Published copy (DOI)

Author(s)

Department/unit(s)

Publication details

JournalEuropean Heart Journal — Quality of Care & Clinical Outcomes
DateAccepted/In press - 18 Dec 2015
DateE-pub ahead of print - 20 Jan 2016
DatePublished (current) - 1 Apr 2016
Issue number2
Volume2
Number of pages140
Pages (from-to)125
Early online date20/01/16
Original languageEnglish

Abstract

Aims To examine long term health care utilisation and costs of patients with stable coronary artery disease (SCAD).
Methods and results Linked cohort study of 94,966 patients with SCAD in England, 1st January 2001 to 31st March 2010, identified from primary care, secondary care, disease and death registries. Resource use and costs, and cost predictors by time and 5-year cardiovascular (CVD) risk profile were estimated using generalised linear models.

Coronary heart disease hospitalisations were 20.5% in the first year and 66% in the year following a non-fatal (myocardial infarction, ischaemic or haemorrhagic stroke) event. Mean health care costs were £3,133 per patient in the first year and £10,377 in the year following a non-fatal event. First year predictors of cost included sex (mean cost £549 lower in females); SCAD diagnosis (NSTEMI cost £656 more than stable angina); and co-morbidities (heart failure cost £657 more per patient). Compared with lower risk patients (5-year CVD risk 3.5%), those of higher risk (5-year CVD risk 44.2%) had higher 5-year costs (£23,393 vs. £9,335) and lower lifetime costs (£43,020 vs. £116,888).
Conclusion Patients with SCAD incur substantial health care utilisation and costs, which varies and may be predicted by 5-year CVD risk profile. Higher risk patients have higher initial but lower lifetime costs than lower risk patients as a result of shorter life expectancy. Improved cardiovascular survivorship among an ageing CVD population is likely to require stratified care in anticipation of the burgeoning demand.

Bibliographical note

© Authors 2016

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations